Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.48 -0.02 (-4.00%)
As of 06/4/2025 12:54 PM Eastern

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.47
$0.50
50-Day Range
$0.43
$0.59
52-Week Range
$0.31
$0.70
Volume
2,730 shs
Average Volume
8,782 shs
Market Capitalization
$11.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Pharma-Bio Serv Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

PBSV MarketRank™: 

Pharma-Bio Serv scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pharma-Bio Serv.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pharma-Bio Serv is -16.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pharma-Bio Serv is -16.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pharma-Bio Serv has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Pharma-Bio Serv's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Pharma-Bio Serv has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma-Bio Serv has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Percentage of Shares Shorted

    0.00% of the float of Pharma-Bio Serv has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma-Bio Serv has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Pharma-Bio Serv this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pharma-Bio Serv insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.20% of the stock of Pharma-Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Pharma-Bio Serv's insider trading history.
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PBSV Returns to Growth
Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks.
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.5499 at the start of the year. Since then, PBSV stock has decreased by 12.7% and is now trading at $0.48.
View the best growth stocks for 2025 here
.

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) released its quarterly earnings data on Monday, March, 17th. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.35. The business had revenue of $2.47 million for the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a negative net margin of 8.18% and a negative trailing twelve-month return on equity of 5.61%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Record date for 3/20 Dividend
2/28/2025
Ex-Dividend for 3/20 Dividend
2/28/2025
Last Earnings
3/17/2025
Dividend Payable
3/20/2025
Today
6/06/2025
Next Earnings (Estimated)
6/13/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Management consulting services
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
Employees
185
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
4.36
P/E Growth
N/A
Net Income
-$780 thousand
Pretax Margin
-7.94%

Debt

Sales & Book Value

Annual Sales
$9.51 million
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
0.80

Miscellaneous

Free Float
20,162,000
Market Cap
$11.01 million
Optionable
Not Optionable
Beta
0.64

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 6/6/2025 by MarketBeat.com Staff
From Our Partners